| Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer (NCT06196671) | Fudan University | 2026-12-01 |
| An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Bevacizumab in First to Third Line BLIS Subtype TNBC (NCT07669610) | Fudan University | 2026-10-01 |
| ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer (NCT07423611) | Fudan University | 2026-10-01 |
| Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery (NCT07762924) | Fudan University | 2026-09-01 |
| APEX-STROKE CALM-ICH Domain (NCT07752719) | Fudan University | 2026-09-01 |
| GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma (NCT07768943) | Fudan University | 2026-09-01 |
| A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients (NCT07694973) | Fudan University | 2026-08-29 |
| Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma (NCT07762976) | Fudan University | 2026-08-01 |
| AI-Guided TURBT for Bladder Cancer (NCT07727343) | Fudan University | 2026-08-01 |
| Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy (NCT07200570) | Fudan University | 2026-08-01 |
| Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer (NCT07771881) | Fudan University | 2026-08-01 |
| Real-World Study of Young Patients With Solid Tumors in China (NCT07708935) | Fudan University | 2026-07-31 |
| Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer (NCT07441369) | Fudan University | 2026-07-30 |
| PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC (NCT07697859) | Fudan University | 2026-07-15 |
| Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01) (NCT07662863) | Fudan University | 2026-07-15 |
| Dietary Pattern Intervention for Neurodevelopment in Preterm Infants (NCT07702734) | Fudan University | 2026-07-01 |
| Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery (NCT07762885) | Fudan University | 2026-07-01 |
| SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer (NCT07619911) | Fudan University | 2026-07-01 |
| Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer (NCT07410559) | Fudan University | 2026-07-01 |
| Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Chemotherapy as Neoadjuvant Therapy for Advanced Ovarian Cancer (NCT07663513) | Fudan University | 2026-07-01 |
| Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer (NCT07683403) | Fudan University | 2026-06-30 |
| Nectin-4 PET to Predict Response to Nectin-4-Targeted Therapy in Advanced Breast Cancer (NCT07708922) | Fudan University | 2026-06-30 |
| The Effects of Different Anesthetics on the Brain's Neural Networks (NCT07644663) | Fudan University | 2026-06-09 |
| A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy. (NCT07666555) | Fudan University | 2026-06-06 |
| Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients. (NCT07610733) | Fudan University | 2026-06-01 |
| Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer (NCT07581795) | Fudan University | 2026-06-01 |
| Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Undergoing Elective Inguinal Hernia Repair (NCT07602647) | Fudan University | 2026-06-01 |
| Probiotics Supplementation for Neurodevelopment in Preterm Infants (NCT07617181) | Fudan University | 2026-06-01 |
| Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer (NCT07490119) | Fudan University | 2026-06-01 |
| Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial (NCT07527520) | Fudan University | 2026-06-01 |
| AI-empowered Nudge to Improve Colonoscopy Uptake (AINC) (NCT07612436) | Fudan University | 2026-05-30 |
| Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations (NCT07628504) | Fudan University | 2026-05-18 |
| Association Between Screening Behaviors and Lung Cancer Spectrum (NCT07626177) | Fudan University | 2026-05-14 |
| A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy (NCT07604909) | Fudan University | 2026-05-10 |
| Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy (NCT07528716) | Fudan University | 2026-05-06 |
| A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer (NCT07573397) | Fudan University | 2026-05-06 |
| Opportunistic Breast Cancer Screening Using Non-Contrast Chest CT (NCT07557654) | Fudan University | 2026-05-06 |
| Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer (NCT07490210) | Fudan University | 2026-05-01 |
| Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC (NCT07554846) | Fudan University | 2026-05-01 |
| A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer (NCT07497919) | Fudan University | 2026-05-01 |
| SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer (NCT07551479) | Fudan University | 2026-05-01 |
| Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC (NCT07403136) | Fudan University | 2026-04-30 |
| Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma (NCT07533357) | Fudan University | 2026-04-20 |
| Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma (NCT07536789) | Fudan University | 2026-04-17 |
| QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC. (NCT07509515) | Fudan University | 2026-04-15 |
| Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies (NCT07459309) | Fudan University | 2026-04-13 |
| Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07507916) | Fudan University | 2026-04-01 |
| Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study (NCT07647016) | Fudan University | 2026-04-01 |
| Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer (NCT07503639) | Fudan University | 2026-04-01 |
| Anlotinib and Benmelstobart in DTC (NCT07193186) | Fudan University | 2026-04-01 |
| Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma (NCT07514793) | Fudan University | 2026-04-01 |
| Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical Study (NCT07755423) | Fudan University | 2026-04-01 |
| Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco) (NCT07353437) | Fudan University | 2026-03-31 |
| CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon） (NCT07432178) | Fudan University | 2026-03-31 |
| A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors. (NCT06889610) | Fudan University | 2026-03-30 |
| Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial (NCT06943794) | Fudan University | 2026-03-30 |
| Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma (NCT07300514) | Fudan University | 2026-03-27 |
| Digital Mind-Body Therapy for Neoadjuvant Breast Cancer (NCT07541664) | Fudan University | 2026-03-25 |
| Mesh Infection After Hernioplasty: Complete vs Partial Removal - Retrospective Study on Outcomes and Pathogen Analysis (NCT07491250) | Fudan University | 2026-03-18 |
| Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases (NCT07466927) | Fudan University | 2026-03-15 |
| Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer (NCT07471776) | Fudan University | 2026-03-11 |
| Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma. (NCT07469241) | Fudan University | 2026-03-10 |
| SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC (NCT07451795) | Fudan University | 2026-03-02 |
| Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADC (NCT07480694) | Fudan University | 2026-03-01 |
| Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC (NCT07412054) | Fudan University | 2026-03-01 |
| A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI (NCT07419867) | Fudan University | 2026-03-01 |
| Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 Subtype (NCT07382687) | Fudan University | 2026-02-26 |
| A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC (NCT07418879) | Fudan University | 2026-02-05 |
| Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC (NCT07398937) | Fudan University | 2026-02-05 |
| Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM. (NCT07638852) | Fudan University | 2026-02-02 |
| Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer (NCT07308379) | Fudan University | 2026-02-01 |
| Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer (NCT07403877) | Fudan University | 2026-02-01 |
| Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma (NCT07347444) | Fudan University | 2026-02-01 |
| FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer (NCT07418866) | Fudan University | 2026-02-01 |
| Adjuvant Intensification for LAR (NCT07407517) | Fudan University | 2026-02-01 |
| Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases (NCT07391007) | Fudan University | 2026-01-31 |
| An Observational Study on Gastric Cancer in High-risk Individuals (NCT07438418) | Fudan University | 2026-01-31 |
| Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS) (NCT07362836) | Fudan University | 2026-01-31 |
| Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer (NCT07419880) | Fudan University | 2026-01-30 |
| RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma (NCT07445022) | Fudan University | 2026-01-28 |
| Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients (NCT07358520) | Fudan University | 2026-01-28 |
| Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification (NCT07319429) | Fudan University | 2026-01-25 |
| A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma (NCT07328009) | Fudan University | 2026-01-19 |
| RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure (NCT07366840) | Fudan University | 2026-01-16 |
| Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer (NCT07368543) | Fudan University | 2026-01-16 |
| Huaier Granule and Proteinuria (NCT07355361) | Fudan University | 2026-01-15 |
| Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors (NCT07319949) | Fudan University | 2026-01-15 |
| Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma (NCT07394244) | Fudan University | 2026-01-09 |
| Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR (NCT07371273) | Fudan University | 2026-01-07 |
| MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer (NCT07692230) | Fudan University | 2026-01-06 |
| G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation (NCT07362810) | Fudan University | 2026-01-01 |
| Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders (NCT07381738) | Fudan University | 2026-01-01 |
| AI for Renal Tumors Using Non-Contrast CT (NCT07304492) | Fudan University | 2026-01-01 |
| Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases (NCT07623577) | Fudan University | 2026-01-01 |
| Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes (NCT07272109) | Fudan University | 2026-01-01 |
| Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer (NCT07517107) | Fudan University | 2026-01-01 |
| Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC (NCT07290153) | Fudan University | 2026-01-01 |
| A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma (NCT07355855) | Fudan University | 2026-01-01 |
| A Phase II Study to Evaluate the Efficacy and Safety of Anti-HER2 Triple-targeted Drugs Combined With CDK4/6 Inhibitors in Neoadjuvant Therapy for ER-positive HER2-positive Breast Cancer Patients. (NCT07290166) | Fudan University | 2025-12-31 |
| Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial (NCT07286110) | Fudan University | 2025-12-30 |